Urovant Sciences Ltd. Insider Trading for May 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Urovant Sciences Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Urovant Sciences Ltd. for May 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,732,710 | 22.7 M to 22.7 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
| May 28 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
| May 28 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 0 | -4,802 to 0 (-100.00 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 9,995.00 | 9,995 | 99,900,025 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
| May 22 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 22,725,277 | 22.7 M to 22.7 M (+0.01 %) |
| May 22 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 22,723,562 | 22.7 M to 22.7 M (+0.04 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.39 | 1,714 | 14,375 | 22,725,277 | 22.7 M to 22.7 M (+0.01 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 22,723,562 | 22.7 M to 22.7 M (+0.04 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 22,715,277 | 22.7 M to 22.7 M (+0.03 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 22,725,277 | 22.7 M to 22.7 M (+0.01 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 22,723,562 | 22.7 M to 22.7 M (+0.04 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 22,715,277 | 22.7 M to 22.7 M (+0.03 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 22,725,277 | 22.7 M to 22.7 M (+0.01 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 22,723,562 | 22.7 M to 22.7 M (+0.04 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 22,715,277 | 22.7 M to 22.7 M (+0.03 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 22,725,277 | 22.7 M to 22.7 M (+0.01 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 22,723,562 | 22.7 M to 22.7 M (+0.04 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 22,715,277 | 22.7 M to 22.7 M (+0.03 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 22,725,277 | 22.7 M to 22.7 M (+0.01 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 22,723,562 | 22.7 M to 22.7 M (+0.04 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 22,715,277 | 22.7 M to 22.7 M (+0.03 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 0 | -1,715 to 0 (-100.00 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 0 | -8,285 to 0 (-100.00 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 0 | -6,200 to 0 (-100.00 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 0 | -1,715 to 0 (-100.00 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 0 | -8,285 to 0 (-100.00 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 0 | -6,200 to 0 (-100.00 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 22,715,277 | 22.7 M to 22.7 M (+0.03 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |